These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

355 related items for PubMed ID: 27560521

  • 21. Recombinant ADAMTS13 reduces tissue plasminogen activator-induced hemorrhage after stroke in mice.
    Wang L, Fan W, Cai P, Fan M, Zhu X, Dai Y, Sun C, Cheng Y, Zheng P, Zhao BQ.
    Ann Neurol; 2013 Feb; 73(2):189-98. PubMed ID: 23280993
    [Abstract] [Full Text] [Related]

  • 22. Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator.
    Wang X, Lee SR, Arai K, Lee SR, Tsuji K, Rebeck GW, Lo EH.
    Nat Med; 2003 Oct; 9(10):1313-7. PubMed ID: 12960961
    [Abstract] [Full Text] [Related]

  • 23. Thrombolysis in experimental cerebral amyloid angiopathy and the risk of secondary intracerebral hemorrhage.
    Reuter B, Grudzenski S, Chatzikonstantinou E, Meairs S, Ebert A, Heiler P, Schad LR, Staufenbiel M, Hennerici MG, Fatar M.
    Stroke; 2014 Aug; 45(8):2411-6. PubMed ID: 25005438
    [Abstract] [Full Text] [Related]

  • 24. Plasma kallikrein mediates brain hemorrhage and edema caused by tissue plasminogen activator therapy in mice after stroke.
    Simão F, Ustunkaya T, Clermont AC, Feener EP.
    Blood; 2017 Apr 20; 129(16):2280-2290. PubMed ID: 28130211
    [Abstract] [Full Text] [Related]

  • 25. Plasma cellular-fibronectin concentration predicts hemorrhagic transformation after thrombolytic therapy in acute ischemic stroke.
    Castellanos M, Leira R, Serena J, Blanco M, Pedraza S, Castillo J, Dávalos A.
    Stroke; 2004 Jul 20; 35(7):1671-6. PubMed ID: 15166391
    [Abstract] [Full Text] [Related]

  • 26. Tissue plasminogen activator promotes matrix metalloproteinase-9 upregulation after focal cerebral ischemia.
    Tsuji K, Aoki T, Tejima E, Arai K, Lee SR, Atochin DN, Huang PL, Wang X, Montaner J, Lo EH.
    Stroke; 2005 Sep 20; 36(9):1954-9. PubMed ID: 16051896
    [Abstract] [Full Text] [Related]

  • 27. Sodium Tanshinone IIA Sulfonate Enhances Effectiveness Rt-PA Treatment in Acute Ischemic Stroke Patients Associated with Ameliorating Blood-Brain Barrier Damage.
    Ji B, Zhou F, Han L, Yang J, Fan H, Li S, Li J, Zhang X, Wang X, Chen X, Xu Y.
    Transl Stroke Res; 2017 Aug 20; 8(4):334-340. PubMed ID: 28243834
    [Abstract] [Full Text] [Related]

  • 28. TGF-β1 prevents blood-brain barrier damage and hemorrhagic transformation after thrombolysis in rats.
    Cai Y, Liu X, Chen W, Wang Z, Xu G, Zeng Y, Ma Y.
    Exp Neurol; 2015 Apr 20; 266():120-6. PubMed ID: 25708985
    [Abstract] [Full Text] [Related]

  • 29. Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke.
    Wang X, Tsuji K, Lee SR, Ning M, Furie KL, Buchan AM, Lo EH.
    Stroke; 2004 Nov 20; 35(11 Suppl 1):2726-30. PubMed ID: 15459442
    [Abstract] [Full Text] [Related]

  • 30. Blood pressure management and evolution of thrombolysis-associated intracerebral hemorrhage in acute ischemic stroke.
    Mokin M, Kass-Hout T, Kass-Hout O, Zivadinov R, Mehta B.
    J Stroke Cerebrovasc Dis; 2012 Nov 20; 21(8):852-9. PubMed ID: 21703878
    [Abstract] [Full Text] [Related]

  • 31. Urgent carotid intervention is safe after thrombolysis for minor to moderate acute ischemic stroke.
    Bazan HA, Zea N, Jennings B, Smith TA, Vidal G, Sternbergh WC.
    J Vasc Surg; 2015 Dec 20; 62(6):1529-38. PubMed ID: 26412434
    [Abstract] [Full Text] [Related]

  • 32. The impact of intracranial carotid artery calcification on the development of thrombolysis-induced intracerebral hemorrhage.
    Lin TC, Chao TH, Shieh Y, Lee TH, Chang YJ, Lee JD, Peng TI, Chang KC, Liou CW, Chang TY, Hung KL, Chang CH.
    J Stroke Cerebrovasc Dis; 2013 Nov 20; 22(8):e455-62. PubMed ID: 23800497
    [Abstract] [Full Text] [Related]

  • 33. Whole body hypothermia extends tissue plasminogen activator treatment window in the rat model of embolic stroke.
    Hassanipour M, Zarisfi M, Ehsani V, Allahtavakoli M.
    Life Sci; 2020 Sep 01; 256():117450. PubMed ID: 32087233
    [Abstract] [Full Text] [Related]

  • 34. Severe renal impairment is associated with symptomatic intracerebral hemorrhage after thrombolysis for ischemic stroke.
    Tütüncü S, Ziegler AM, Scheitz JF, Slowinski T, Rocco A, Endres M, Nolte CH.
    Stroke; 2013 Nov 01; 44(11):3217-9. PubMed ID: 24003042
    [Abstract] [Full Text] [Related]

  • 35. The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST.
    Flint AC, Gupta R, Smith WS, Kamel H, Faigeles BS, Cullen SP, Rao VA, Bath PM, Wahlgren N, Ahmed N, Donnan GA, SITS International and VISTA-plus investigators.
    Int J Stroke; 2014 Aug 01; 9(6):705-10. PubMed ID: 25042855
    [Abstract] [Full Text] [Related]

  • 36. The rtPA increases MMP-9 activity in serum during ischaemic stroke.
    Gołąb P, Boguszewska-Czubara A, Kiełbus M, Kurzepa J.
    Neurol Neurochir Pol; 2014 Aug 01; 48(5):309-14. PubMed ID: 25440008
    [Abstract] [Full Text] [Related]

  • 37. Metalloproteinase inhibition reduces thrombolytic (tissue plasminogen activator)-induced hemorrhage after thromboembolic stroke.
    Lapchak PA, Chapman DF, Zivin JA.
    Stroke; 2000 Dec 01; 31(12):3034-40. PubMed ID: 11108768
    [Abstract] [Full Text] [Related]

  • 38. Phosphorylated recombinant HSP27 protects the brain and attenuates blood-brain barrier disruption following stroke in mice receiving intravenous tissue-plasminogen activator.
    Shimada Y, Shimura H, Tanaka R, Yamashiro K, Koike M, Uchiyama Y, Urabe T, Hattori N.
    PLoS One; 2018 Dec 01; 13(5):e0198039. PubMed ID: 29795667
    [Abstract] [Full Text] [Related]

  • 39. Outcome and severe hemorrhagic complications of intravenous thrombolysis with tissue plasminogen activator in very old (> or =80 years) stroke patients.
    Berrouschot J, Röther J, Glahn J, Kucinski T, Fiehler J, Thomalla G.
    Stroke; 2005 Nov 01; 36(11):2421-5. PubMed ID: 16210554
    [Abstract] [Full Text] [Related]

  • 40. Matrix Metalloproteinase-9 Expression is Enhanced by Ischemia and Tissue Plasminogen Activator and Induces Hemorrhage, Disability and Mortality in Experimental Stroke.
    Saleem S, Wang D, Zhao T, Sullivan RD, Reed GL.
    Neuroscience; 2021 Apr 15; 460():120-129. PubMed ID: 33465414
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.